Core Insights - Breckenridge Distillery has launched Mock One, a new line of non-alcoholic spirits crafted to deliver the complexity and depth of traditional spirits without alcohol [1][4][7] - Mock One is designed for health-conscious consumers and mindful drinkers, offering sophisticated options for crafted cocktails [3][4][7] Product Details - Mock One includes expressions inspired by whiskey, gin, tequila, and rum, featuring bold and nuanced flavor profiles [7] - The tasting notes for Mock One products include: - Mock One Whiskey: oak, cinnamon, vanilla bean, honey [6] - Mock One Gin: juniper, Meyer lemon, kaffir lime, lavender [6] - Mock One Tequila: agave, vanilla bean, honey capsaicin [6] - Mock One Rum: vanilla bean, brown sugar, cola nut, oak [6] Market Availability - Mock One is currently available in Colorado retailers and online nationwide, with plans for broader retail distribution this fall [4][7] Company Background - Breckenridge Distillery, founded in 2008, is known for its award-winning blended bourbon whiskey and has received numerous accolades, including nine Icons of Whisky awards [1][10][12]

Core Insights - Tilray Brands has experienced a significant decline in stock price, dropping over 99% from its peak of nearly $150 due to various industry challenges [1][2] - Recent stock performance shows a 55% increase in a one-month span, raising questions about potential long-term recovery driven by improved cash flow and regulatory changes [2] Financial Performance - The 12-month stock price forecast for Tilray is $1.92, indicating a potential upside of 204.23% from the current price of $0.63 [3] - The company has improved its cannabis gross margins to 41%, up from 33% a year earlier, and achieved an overall gross margin of 28% compared to 26% in the prior year [4] - Tilray has successfully reduced its debt, with levels now under 1x its trailing 12-month EBITDA [4][6] - Fiscal 2025 revenue estimates have been revised down to $850 million to $900 million from a previous range of $950 million to $1 billion [6] Regulatory Environment - There is optimism regarding potential regulatory changes under the second Trump administration, particularly the possible reclassification of cannabis by the DEA [7][8] - The rescheduling process for cannabis has faced delays, but may resume with the confirmation of a new DEA Administrator [8] Product and Market Expansion - Tilray has expanded its product lineup, including new summer cannabis products and a significant beverage portfolio acquired from Anheuser-Busch [9][10] - The company has received authorization from the Italian Ministry of Health to import and distribute proprietary medical cannabis flowers, enhancing its position in the European market [11]

Why One-Time Cannabis Darling Tilray Is Now High On Beer https://t.co/jmIGlbt96I https://t.co/jmIGlbt96I ...

Core Viewpoint - Tilray Brands, Inc. is set to release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, on July 28, 2025, after market close [1] Group 1: Financial Results Announcement - The financial results will be announced after market close on July 28, 2025 [1] - A live conference call and audio webcast will be held to discuss these results at 4:30 PM Eastern Time on the same day [2] Group 2: Company Overview - Tilray is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America [3] - The company focuses on the cannabis, beverage, wellness, and entertainment industries, aiming to elevate lives through moments of connection [3] - Tilray supports over 40 brands in over 20 countries, offering comprehensive cannabis products, hemp-based foods, and craft beverages [3]

Core Insights - The article highlights the investment strategies and achievements of Paul Franke, a seasoned investor with 39 years of trading experience, emphasizing his contrarian stock selection style and the development of a system called "Victory Formation" for identifying stocks based on supply/demand imbalances [1] Group 1: Investment Strategies - Paul Franke suggests using 10% or 20% stop-loss levels on individual stock choices to manage risk effectively [1] - A diversified approach is recommended, advocating for ownership of at least 50 well-positioned stocks to achieve consistent outperformance in the stock market [1] - The "Bottom Fishing Club" articles focus on identifying deep value candidates or stocks that are experiencing significant upward technical momentum reversals [1] Group 2: Analytical Approach - Franke employs daily algorithm analysis of both fundamental and technical data to enhance stock selection [1] - The "Volume Breakout Report" articles discuss positive trend changes that are supported by strong price and volume trading actions, indicating potential investment opportunities [1]

Core Insights - Tilray Brands, Inc. is hosting a series of Independence Day events across its craft beer taprooms in the U.S. to enhance the holiday experience [1] - The events will feature live music, limited-release brews, barbecues, and unique local festivities [1][16] Event Highlights - Atwater Brewery in Detroit is offering a BBQ deal for $15, which includes a cheeseburger or two hot dogs, two sides, and a beer [3] - 10 Barrel Brewing in East Bend, OR, will have food and drink specials, a best-dressed patriotic contest, and fireworks, with all activities free for all ages [4] - Blue Point Brewing Co will host live music and to-go beer specials, with a special event at the Boardy Barn on July 6, featuring a cover charge and various drink specials [6] - Breckenridge Brewery will feature an 80-piece orchestra and fireworks on July 3, with ticket prices ranging from $14 to $475 for VIP tables [8] - Montauk Brewing Company released a limited-edition beer for its anniversary and will offer it throughout the July 4 week [10] - SweetWater Brewing Co will participate in the Peachtree Road Race and host live music and food specials over the weekend [12] - Terrapin Beer Co will have various activities including beer specials, BBQ food trucks, and contests [14] Company Overview - Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with operations in multiple regions including North America, Europe, and Latin America [17] - The company aims to be a transformative force at the intersection of cannabis, beverage, wellness, and entertainment, focusing on creating memorable experiences [17][18]

Core Insights - Breckenridge Distillery has launched its fifth edition of the Collectors Art Series, collaborating with artist Miles Toland for the label design of the new Calvados Cask Finish whiskey [1][7] - The limited release is bottled at 95 proof (47.5% ABV) and features tasting notes of red apples, oak, vanilla, and cinnamon [5][8] - A portion of the proceeds, specifically $5 per bottle, will be donated to Keep RiNo Wild, supporting community creative spaces and educational programs [6] Company Overview - Breckenridge Distillery, founded in 2008, is recognized as the "World's Highest Distillery" and is known for its award-winning blended bourbon whiskey [11][12] - The distillery has received numerous accolades, including multiple awards at the World Whiskies Awards and the San Francisco World Spirits Competition [12][7] - Breckenridge Distillery is a subsidiary of Tilray Brands, Inc., a leading company in the cannabis-lifestyle and consumer packaged goods sector [14]

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $0.40, moving -2.84% from the previous trading session. The stock fell short of the S&P 500, which registered a gain of 0.52% for the day. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 0.52%. The company's shares have seen a decrease of 11.24% over the last month, not keeping up with the Medical sector's gain of 3.5% and the S&P 500's gain of 5.95%.Analysts and investors alike will be keeping a close eye on the perfor ...

Core Insights - Montauk Brewing Co. and Faherty have partnered to create a limited-edition summer beer and apparel collection that reflects the essence of coastal living [1][2] - The collaboration celebrates Montauk Brewing's 13th anniversary with a new tropical beer called The Après Surf Beer, featuring pineapple and coconut flavors [2][4] - The partnership aims to enhance community engagement through a beach cleanup event in collaboration with the Eastern Long Island Chapter of Surfrider Foundation [6] Company Overview - Montauk Brewing Company was founded in 2012 and focuses on crafting exceptional brews while promoting a lifestyle of adventure and enjoyment [8] - Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company with a diverse portfolio, including cannabis, beverages, and wellness products [10] - Faherty, established in 2013, is a family-owned brand committed to sustainable craftsmanship and social impact, with over 78 stores nationwide [12]

Core Insights - A new study published by Tilray Medical focuses on the bioavailability of different cannabinoid formulations, specifically comparing Tilray's THC:CBD extract and nabiximols [1][4] Group 1: Study Overview - The study assessed pharmacokinetic parameters and relative bioavailability of two formulations: Tilray THC:CBD extract (10 mg/mL each of THC and CBD) and nabiximols (total dose of 10.8 mg THC and 10 mg CBD) [2] - Conducted with twelve healthy volunteers, the study revealed that the Cmax for THC and CBD was significantly higher for the Tilray extract compared to nabiximols [3] Group 2: Key Findings - The study found that THC and CBD were undetectable 24 hours post-dose, and 11-OH-THC was markedly reduced from its peak [3] - No serious adverse events were reported during the study, indicating a favorable safety profile for the Tilray formulation [3] Group 3: Implications and Future Directions - The findings suggest that the oral administration of Tilray's THC:CBD extract may achieve higher cannabinoid concentrations more quickly than nabiximols, which could have significant implications for therapeutic use [4] - Tilray's Medical Director emphasized the importance of understanding cannabinoid pharmacokinetics to enhance therapeutic outcomes [5]